Previous 10 | Next 10 |
Clinical-stage biotech Cassava Sciences (NASDAQ:SAVA) responded to charges of research wrongdoing on Wednesday after it was reported that the U.S. Department of Justice had opened a criminal investigation into the company's experimental Alzheimer's treatment. According to Chie...
Clinical-stage biotech Cassava Sciences ( NASDAQ: SAVA ) countered allegations of research misconduct on Wednesday after Reuters reported that the U.S. Justice Department had initiated a criminal probe related to the company’s experimental Alzheimer’s drug. ...
- In November 2021, Cassava Sciences previously disclosed that certain government agencies had asked for corporate information and at that time, the media widely reported on these prior disclosures. - No government agency has informed Cassava Sciences that it has found any evide...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: IgorGolovniov / Shutterstock.com Alphabet (NASDAQ: GOOG , GOOGL ) stock is on the rise Wednesday as investors react to the tech giant’s earnings report for the second quarter of 2022 . The ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Fabio Principe / Shutterstock.com Spotify (NYSE: SPOT ) stock is on the rise Wednesday as investors react to a strong earnings report for the second quarter of 2022. In that report, Spotify notes tha...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cassava Biosciences (NASDAQ: SAVA ) stock is tumbling 30% in pre-market trading after Reuters reported today that the Justice Department has launched a criminal probe of the company. The news service cited two unn...
Gainers: Blue Water Vaccines ( BWV ) +69% . Leafly Holdings ( LFLY ) +25% . AlloVir ( ALVR ) +23% . Teva Pharmaceutical ( TEVA ) +21% . Nutriband ( NTRB ) +17% . Losers: ObsEva ( OBSV ) -68% . Cassava Scie...
The shares of clinical-stage biotech Cassava Sciences ( NASDAQ: SAVA ) crashed ~44% in the pre-market after Reuters reported on Wednesday that the U.S. Justice Department had opened a criminal investigation linked to its experimental Alzheimer’s therapy simufilam. ...
NEW YORK, July 25, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Enochian Biosciences, Inc. (NASDAQ: ENOB), Corcept Therapeutics, Inc. (NASDAQ: CORT), Cassava Sciences, Inc. (NASDAQ: S...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
News, Short Squeeze, Breakout and More Instantly...
Cassava Sciences, Inc. (NASDAQ: SAVA) is one of today's top gainers. The company's shares have moved 24.9% on the day to $12.59. Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 6.6% to $117.99 on volume of 383,510,118 shares Aptevo Therapeutics Inc. (APVO) rose 73.4% to $0.581 on volume of 315,289,581 shares PROSHARES TRUST (SQQQ) rose 8.7% to $8.11 on volume of 173,682,364 sha...